FACULTY
Treating Hypercholesterolemia in Women
Paper Symposium
Activity Date: July 2002  — Activity Info: Volume 2, (11)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

CHAIR

    Roger S. Blumenthal, MD
    Director of Preventive Cardiology
    The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Blumenthal reports receiving grants and research support from Merck, Pfizer, Wyeth-Ayerst, Bristol-Myers Squibb, and Novartis; receiving honoraria from Merck, Pfizer, Medcom, and Physicians World.

PARTICIPATING FACULTY

    Sandra Lewis, MD
    Director of Research
    Portland Cardiovascular Institute
    Associate Clinical Professor
    Oregon Health Sciences University
    Portland, Oregon
    • Dr Lewis reports receiving grants and research support from Pfizer, Bristol-Myers Squibb, and AstraZeneca; receiving honoraria from Merck, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline.

    Lori Mosca, MD, PhD, MPH
    Director, Preventive Cardiology
    New York Presbyterian Hospital
    New York, New York
    • Dr Mosca reports serving as a consultant for/ on the advisory board of/and on the speakers bureau for Abbott Laboratories, Bayer Corporation, Cholestech Corporation, Kos/Snell, Eli Lilly Research Laboratories, Merck, Novartis, Organon, Pharmacia, Wyeth-Ayerst, Pfizer, and Sankyo Pharma; having research contracts with Eli Lilly Research Laboratories, Organon, and Vasocor.
    • Dr Mosca is funded by a Research Career Award from the National Institutes of Health (KO8 HL 03681).

    Carla A. Sueta, MD, PhD
    Associate Professor of Medicine
    Director of Cardiology Clinics
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina
    • Dr Sueta reports serving as a consultant for Merck; receiving honoraria from Merck and Sankyo Pharma.

    Karol Watson, MD, PhD
    Co-Director
    UCLA Program in Preventive Cardiology
    University of California at Los Angeles
    Redondo Beach, California
    • Dr Watson reports serving as a consultant for AstraZeneca, Merck, and Pfizer.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?